Clayton, one of America's largest builders of manufactured and modular homes, is proud to announce that it is being featured on the new show “Breakneck Builds” to showcase some of its customized modular homes for the debut season.
The series features a total of six different Clayton Built™ homes throughout Season One. Clayton interviewed two of the six families after filming commenced to give a behind-the-scenes look at the homes and the families living in them. The exclusive interviews featured the families of Roger and Jamie Linn, of Tijeras, N.M., and John Broadbooks of Black Hawk, Colo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7413931-clayton-homes-avoid-refund-regret/
It’s the time of year when the automotive universe turns its attention to the heart of the industry, as all roads lead to Detroit in January. The North American International Auto Show (NAIAS) encourages its global journalist audience to begin preparations to attend Press Preview, Jan. 11-12, 2016, at the completely transformed Cobo Center. Widely considered one of the most important automotive events on the planet, NAIAS is consistently the strategic choice of global automakers to launch their new products and automotive technology, and the 2016 show is no exception.
“The industry is truly firing on all cylinders, and that will be reflected at this year’s show,” said Paul Sabatini, 2016 NAIAS Chairman. “Attendees to the 2016 NAIAS will see the most global reveals of any auto show in North America, and will experience them amidst automaker exhibits that are either completely new or significantly enhanced for the upcoming show.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7699851-detroit-2016-naias/
St. Jude Children’s Research Hospital® officials and guests today marked the opening of the St. Jude Red Frog Events Proton Therapy Center, the first proton therapy center in the world dedicated solely to children with cancer.
Patients are now being treated at the center using precisely delivered, high-energy particles called protons to kill or shrink tumors while minimizing damage to healthy tissue and organs. For patients with brain tumors and certain other cancers, research suggests proton beam therapy may be more effective than conventional radiation at preventing the growth and spread of tumors while reducing the risk of treatment-related side effects.
To view the multimedia release go to:
http://www.multivu.com/players/English/7713451-st-jude-proton-therapy-opening/
Crystal Lagoons broke the record for the “World's Largest Crystalline Lagoon” with the completion of its latest project in Egypt.
Twelve Crystal Lagoons totaling 250 acres will be the centerpiece of the $5.5 billion dollar, 1,850-acre development in Citystars Sharm El Sheikh. The record-breaking lagoon is 30 acres of crystal-clear water surrounded by white sandy beaches - perfect for swimming, sailing, kayaking and more.
Citystars Sharm el Sheikh's crystal lagoon get its salt water supply from wells in the middle of the desert that are otherwise useless, allowing for a tropical crystalline lagoon in the desert. In addition, the salt water used in the crystal lagoon features higher levels of purity and will be used for reverse osmosis desalinization processes, lowering the costs of water treatment.
To view the multimedia release go to:
http://www.multivu.com/players/English/7689951-crystal-lagoons-guinness-world-record/
The S90 marks a giant step forward for Volvo Cars. The Swedish car maker is better known for its SUVs and estates, but with the launch of the S90 Volvo is clearly intent on shaking up the premium sedan segment with its distinctive executive class sedan.
Equipped with a host of new technologies ranging from cutting edge safety to cloud-based apps and services, the S90 is further proof of the Swedish brand’s continuing transformation.
“With the launch of the XC90 we made a clear statement of intent. We are now clearly and firmly in the game. With $11 USD billion of investment over the past five years we have not only reimagined what Volvo Cars can be – we are now delivering on our promise of a resurgent and relevant Volvo Cars brand,” said Håkan Samuelsson, President & CEO, Volvo Car Group.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7702651-volvo-stakes-its-claim-with-the-S90/
All of SwegWay Ireland's Smart Wheel Scooter range come with a built-in Bluetooth Speaker, allowing you to glide with purpose while listening to your favourite tunes and an amazingly stylish LED lighting system which is sure to catch the eye. Also included is the incredibleSwegWay Ireland Carry Case and of course the robust charger pack.
We're committed to emerging technology and have brought to market a fantastic range of our very latest SwegWays to Ireland.
It's not enough to just provide these incredible products, we're also breaking down barriers on the price as launch at less than half the price of the major high street retailers.
https://www.swegwayireland.ie
Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
Whether for the rising culinary explorer or the advanced cook needing an extra hand in the kitchen, three new small appliances from KitchenAid are sure to make welcome gifts this holiday season. They include a Multi-Cooker with Stir Tower attachment, Siphon Coffee Brewer, and Spiralizer Attachment for the KitchenAid stand mixer. Further information about the products detailed below can be found at www.KitchenAid.com/Countertop-Appliances
Home cooks likely to multi-task in the kitchen during the holidays should consider one of the latest countertop cooking appliances from KitchenAid: a four quart Multi-Cooker with stir tower, providing 10 cooking functions, step-by-step cooking modes and a stirring accessory that allows for assisted cooking at precise temperatures.
The Multi-Cooker’s pre-programmed settings take the guesswork out of preparing such essentials as rice, risotto, soup and yogurt. Each setting provides cooks with next step instructions to help deliver perfect results. Additional cooking modes include simmering, sautéing, searing, steaming and two slow cook options, all of which can be programmed for up to 12 hours of cooking, plus a Keep Warm function that can be programmed for up to 24 hours. The Multi-Cooker automatically sets the temperature for each setting, while the brand’s Even-Heat™ technology allows for precise temperature regulation between 110° - 450° F to prevent under or over cooking.
To view the multimedia release go to:
http://www.multivu.com/players/English/7558052-kitchenaid-small-appliances-2015/
Carhartt, America’s premium work wear brand since 1889, today launched its national fall integrated marketing campaign focused on the brand’s durable water repellent Rain Defender® technology available in select outerwear, sweatshirts, pants and accessories. The multi-week campaign features search and rescue crewmembers who don’t have the luxury of waiting for good weather; their workdays don’t get rain delays. The campaign will be shown across multiple broadcast and digital channels through December.
“Durable, high performance sweatshirts and outerwear are a necessity for anyone in the rugged outdoors who can’t stop because of weather. Carhartt’s products featuring Rain Defender® keep you dry by making water bead up and run off the fabric,” said Tony Ambroza, senior vice president of marketing at Carhartt. “This fall’s national campaign features real search and rescue crews from Creede, Colorado taking on rain, sleet and snow in a typical day’s work.”
Carhartt’s durable water repellent Rain Defender® gear includes Quick Duck® jackets, vests and bibs, Carhartt’s Shoreline and Force Equator outerwear, bibs and pants and Carhartt’s Rain Defender® equipped sweatshirts – zip-front, hoodie, mock or crewneck styles. Carhartt also offers tool bags and a selection of other gear also equipped to protect against the rain as well.
To view the multimedia release go to:
http://www.multivu.com/players/English/7419252-carhartt-rain-defender/
Leveraging advanced skincare science inspired by the Nobel Prize-winning discovery of Aquaporins, the Artistry Hydra-V™ collection presents a new level of skincare targeting deep hydration. This comprehensive line provides up to 24-hour hydration for skin that feels soft, smooth and supple.
Whatever level of hydration skin needs, the Artistry Hydra-V™ line answers with a range of formulas that can be customized to skin type, season and climate. “Artistry Hydra-V™ products are for the younger consumer who is not yet concerned with the signs of aging but instead want skincare products to give her a beautiful, healthy complexion. This advancement in skincare technology epitomizes the Artistry® Forward Beauty platform and meets the balanced hydration needs of women younger than 35,” says Jackie Nickel, Chief Marketing Officer for the Americas Region. “It’s our first collection to focus on deep hydration for all skin types.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7488157-amway-artistry-hydra-v/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
